Uriel Heresco-levy
Immunology
Hebrew University,
Israel
Biography
Uriel Heresco-Levy is a Full Professor of Psychiatry at Hadassah Medical School, Hebrew University and Director of the Psychiatry Department at Herzog Memorial Hospital, Jerusalem, Israel. He is a Member of the European College of Neuropsychopharmacology (ECNP) and Fellow of Collegium International Neuro- Psychopharmacologicum (CINP). He has conducted pioneer clinical trials with N-methyl-D-aspartate receptor (NMDAR) modulators, including glycine, D-serine and D-cycloserine and has published extensively on the role of NMDAR-mediated neurotransmission and D-serine in neuropsychiatric disorders. He is the inventor of patents focusing on the use of NMDAR-neurotransmission pharmacomodulation in Parkinson's disease, major depressive disorder and autoimmune NMDAR encephalopathies.Uriel Heresco-Levy is a Full Professor of Psychiatry at Hadassah Medical School, Hebrew University and Director of the Psychiatry Department at Herzog Memorial Hospital, Jerusalem, Israel. He is a Member of the European College of Neuropsychopharmacology (ECNP) and Fellow of Collegium International Neuro- Psychopharmacologicum (CINP). He has conducted pioneer clinical trials with N-methyl-D-aspartate receptor (NMDAR) modulators, including glycine, D-serine and D-cycloserine and has published extensively on the role of NMDAR-mediated neurotransmission and D-serine in neuropsychiatric disorders. He is the inventor of patents focusing on the use of NMDAR-neurotransmission pharmacomodulation in Parkinson's disease, major depressive disorder and autoimmune NMDAR encephalopathies.
Research Interest
Immunology
